Back to discover
Disease

Eclampsia

Late-stage therapeutic developmentEmerging research
1
Publications
18
Clinical trials
2022
Latest publication
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this disease.

What's happening now

An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.

Executive briefingUpdating summary…Momentum: Low
Key developments
  • 3 clinical trials expected to report results, the earliest in Q3 2026.
Major developments
Upcoming trial readoutHigh impact
Results expected Q3 20262026-06-04

Clinical trials

15 sponsors · 1 new · 1 completed in the last 12 months (net +1)

The current development programme across all trial phases.

Clinical programme
18
All trials
6
Active
15
Late-stage
6
Completed
Late-stage studies
Recently completed

Research activity

1 papers

Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.

Major themes3
  • Eclampsia1
  • Gastrointestinal Microbiome1
  • Pre-Eclampsia1
Leading journals1
  • BMC medicine1
Leading researchers8
  • Chen G1
  • Fan D1
  • Gou X1
  • Guo L1
  • Guo X1
  • Li P1
  • Lin D1
  • Liu Z1
Affiliations (unnormalised)3
  • Affiliated Foshan Maternity & Child Healthcare Hospital1
  • Foshan Fetal Medicine Research Institute1
  • School of Public Health1

Reference

Authoritative identity, definition & identifiers.

Defined in MeSH

Onset of HYPERREFLEXIA; SEIZURES; or COMA in a previously diagnosed pre-eclamptic patient (PRE-ECLAMPSIA).

Identifiers
References & data sources
  • Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
  • Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
  • Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
  • Related entities are derived from literature co-mention (studied together) — associative, not causal.